-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Acro Biomedical Co., Ltd. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q4 2017 to Q1 2023.
- Acro Biomedical Co., Ltd. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $36.000, a 87.5% decline year-over-year.
- Acro Biomedical Co., Ltd. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $58.1K.
- Acro Biomedical Co., Ltd. annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$222K, a 203% decline from 2020.
- Acro Biomedical Co., Ltd. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $217K, a 842% increase from 2019.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)